英国养老院中的骨质疏松症管理:修改后的德尔菲共识
Sunil Nedungayil1, Shelley Douglas2, Jill Griffin3
1Musculoskeletal, Pain and Rheumatology Services,The Castle Medical Group and East Lancashire Hospital, NHS Trust, Blackburn, UK sunil.nedungayil@nhs.net.
BJGP open
|December 16, 2025
概括
这项研究制定了九项建议,以改善英国养老院的骨质疏松症护理,解决沟通缺口,促进积极的骨健康管理,以获得更好的患者结果.
科学领域:
- 老年医学 老年医学
- 骨健康 骨健康 骨健康
- 骨质疏松症管理管理
背景情况:
- 骨质疏松症是一种慢性疾病,其特点是骨矿物质密度 (BMD) 降低和骨折风险增加.
- 住院养老院人口不成比例地受到骨质疏松症的影响.
研究的目的:
- 制定基于证据的建议,以加强英国养老院的骨质疏松症管理.
- 解决在长期护理环境中对骨质疏松症患者的护理所面临的挑战.
主要方法:
- 一项经过修改的Delphi研究,涉及英国老年医学和骨质疏松症护理专家.
- 开发和调查测试与临床医生和养老院管理人员的45个共识陈述.
- 共识定义为≥75%强烈同意或≥90%非常强烈同意.
主要成果:
- 收到了101份调查答复,共识达到了93.3%的陈述.
- 制定了九项关键建议,以改善骨质疏松症和骨健康护理协调.
- 创建了护理途径,以整合包括养老院在内的初级和中级护理方面的建议.
结论:
- 在英国养老院骨质疏松症管理中存在显著的差距,特别是在沟通方面.
- 积极主动,协调的骨健康方法对于改善患者的治疗结果至关重要.
- 这些建议旨在减轻弱势养老院人口的骨质疏松症负担.
相关概念视频
Documentation in Long-Term and Home Healthcare Setting
1.4K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.4K
Osteoclasts in Bone Remodeling
3.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.8K
Rheumatic Heart Disease IV: Nursing Management
247
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
247
Peripheral Artery Disease III: Interprofessional Care
221
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
221
Peripheral Artery Disease IV: Nursing Management
316
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
316
Atherosclerosis III: Management
293
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
293
